| |  Patient experiences of the post-acute sequelae of coronavirus disease 2019 (COVID-19) or long COVID. | |
|
| |  Researchers designed a cross-sectional study to investigate the biological underpinnings of “Long COVID”, the post-acute infection syndrome triggered by SARS-CoV-2. | |
|
| |  SARS-CoV-2, the virus that causes COVID-19, can directly infect the arteries of the heart and cause the fatty plaque inside arteries to become highly inflamed, increasing the risk of heart attack and stroke, according to a study funded by the National Institutes of Health. | |
|
| |  Researchers examined the antigenicity of the emerging SARS-CoV-2 subvariant BA.2.86, finding that it is not resistant to neutralizing antibodies from previously infected or vaccinated individuals, although it does show increased binding affinity to the ACE-2 receptor. The study highlights the subvariant's sensitivity and resistance to different classes of monoclonal antibodies, offering insights for future treatment and vaccine development. | |
|
| |  A research team at the University of Liverpool has developed a new material that captures coronavirus particles and could transform the efficiency of face masks and other filter equipment to stop the spread of COVID-19 and other viruses. | |
|
| |  The risks of death by suicide for six healthcare worker (HCW). | |
|
| |  New research from the Nuffield Department of Primary Care Health Sciences, the University of Oxford, and the universities of Stirling and Aberdeen funded by the National Institute for Health and Care Research (NIHR), has shone a spotlight on the profound effect Long Covid can have on children and young people's school experience and wider lives. | |
|
| |  Using data from Mass General Brigham's electronic health records, Brigham researchers quantified the burden of SARS-CoV-2-associated sepsis early in the pandemic. | |
|
| |  Researchers characterized the gut microbiota composition associated with the durability of COVID-19 vaccine-induced immunity. | |
|
| |  Researchers from the University of Texas Southwestern have developed an aerosolized, mutated form of ACE2 that effectively neutralizes various SARS-CoV-2 variants in both cell cultures and mice. The study suggests that this modified ACE2 has promising preventive and therapeutic potential against COVID-19, especially with its easy aerosolized administration. | |
|
| |  Study highlights the ability of the Vaxzevria vaccine in inducing robust mucosal antibody responses, especially in COVID-19-recovered individuals, showcasing a notable defense against various SARS-CoV-2 variants. However, it emphasizes the need for booster doses to enhance anti-SARS-CoV-2 mucosal immunity, especially in infection-naïve individuals, to broaden protection against emerging viral variants. | |
|
| |  The U.S. POINTER study aims to explore if lifestyle changes like exercise, diet, and social activities can help preserve cognitive function in older Americans at risk for dementia. Modeled after Finland's successful FINGER study and set to complete in 2025, this extensive research will involve 2,000 participants and focus on diverse and culturally informed strategies. | |
|
| |  Researchers describe the effects of thought suppression on mnemonic, affective, positive, or negative mental health indices. | |
|
| |  "Covid is not pretty in a nursing home," said Deb Wityk, a 70-year-old retired massage therapist who lives in one called Spurgeon Manor, in rural Iowa. She twice contracted the disease and is eager to get the newly approved vaccine because she has chronic lymphocytic leukemia, which weakens her immune system. | |
|
| |  New Cleveland Clinic-led research shows commonly used COVID-19 anti-viral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduce risk of hospitalization and death in high-risk patients with mild disease, even with Omicron subvariants. | |
